Skip to main content
MEDP
NASDAQ Life Sciences

Medpace Sets Q2 2026 Earnings Call for July 22

Reported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$461.6
Mkt Cap
$13.183B
52W Low
$294.07
52W High
$628.916
Market data snapshot near publication time

Summary

Medpace Holdings has scheduled its second quarter 2026 financial results release for July 22, 2026. This announcement provides the market with the official date for the upcoming earnings call. Traders will mark this date to prepare for potential market reactions and to assess the company's performance and updated guidance.

At the time of this announcement, MEDP was trading at $461.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.2B. The 52-week trading range was $294.07 to $628.92. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.

Price Chart

Share this article

Copied!

MEDP - Latest Insights

MEDP
Jun 16, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
7
Medpace Sets Q2 2026 Earnings Call for July 22
Price at Filing: $461.60
Real-time Price: $456.36 info
Change: -$5.24 (-1%) info
Market Cap: $13.033B info
Sentiment: Neutral
View Wiseek Article
MEDP
Jun 04, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Medpace Appoints Brad Hansman as Executive Vice President, Operations
Price at Filing: $458.69
Real-time Price: $456.36 info
Change: -$2.33 (-0.51%) info
Market Cap: $13.033B info
Sentiment: Neutral
View Wiseek Article
MEDP
May 26, 2026, 6:18 AM EDT
Source: PR Newswire
Importance Score:
8
Medpace Faces Securities Fraud Class Action Over Alleged Cancellation Rate Understatement; Lead Plaintiff Deadline June 8
Price at Filing: $432.80
Real-time Price: $456.36 info
Change: +$23.56 (+5%) info
Market Cap: $13.033B info
Sentiment: Negative
View Wiseek Article
MEDP
May 19, 2026, 2:43 PM EDT
Filing Type: 8-K
Importance Score:
8
Medpace Shareholders Approve Major Governance Changes, Empowering Shareholder Action
Price at Filing: $423.59
Real-time Price: $456.36 info
Change: +$32.77 (+8%) info
Market Cap: $13.033B info
Sentiment: Neutral
View Wiseek Article
MEDP
May 12, 2026, 6:46 AM EDT
Source: PR Newswire
Importance Score:
8
Securities Fraud Class Action Filed Against Medpace Over Alleged Misrepresentation of Key Metrics
Price at Filing: $417.29
Real-time Price: $456.36 info
Change: +$39.07 (+9%) info
Market Cap: $13.033B info
Sentiment: Negative
View Wiseek Article
MEDP
Apr 22, 2026, 4:26 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Medpace Holdings Projects 2026 Revenue Between $2.76 Billion and $2.86 Billion
Price at Filing: $430.00
Real-time Price: $456.36 info
Change: +$26.36 (+6%) info
Market Cap: $13.033B info
Sentiment: Neutral
View Wiseek Article
MEDP
Apr 22, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Medpace President Resigns; CEO August Troendle Temporarily Reassumes Role
Price at Filing: $420.01
Real-time Price: $456.36 info
Change: +$36.35 (+9%) info
Market Cap: $13.033B info
Sentiment: Neutral
View Wiseek Article
MEDP
Apr 22, 2026, 4:15 PM EDT
Source: Reuters
Importance Score:
7
Medpace Beats Q1 Revenue Estimates with $706.6M Sales, Reports $123.87M Net Income
Price at Filing: $420.00
Real-time Price: $456.36 info
Change: +$36.36 (+9%) info
Market Cap: $13.033B info
Sentiment: Positive
View Wiseek Article
MEDP
Apr 01, 2026, 4:42 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Medpace Proposes Key Governance Changes to Empower Shareholders at Annual Meeting
Price at Filing: $489.48
Real-time Price: $456.36 info
Change: -$33.12 (-7%) info
Market Cap: $13.033B info
Sentiment: Positive
View Wiseek Article
MEDP
Mar 19, 2026, 4:45 PM EDT
Filing Type: 4
Importance Score:
7
Medpace President Sells $14.4M in Shares Following Option Exercise
Price at Filing: $460.92
Real-time Price: $456.36 info
Change: -$4.56 (-0.99%) info
Market Cap: $13.033B info
Sentiment: Negative
View Wiseek Article